OTCPK:FZMD

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Fuse Medical, Inc. manufactures and distributes medical devices implants in the United States. More Details


Snowflake Analysis

Weak fundamentals or lack of information.


Similar Companies

Share Price & News

How has Fuse Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: FZMD's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

42.9%

FZMD

1.6%

US Healthcare

1.0%

US Market


1 Year Return

n/a

FZMD

15.9%

US Healthcare

13.6%

US Market

Return vs Industry: Insufficient data to determine how FZMD performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how FZMD performed against the US Market.


Shareholder returns

FZMDIndustryMarket
7 Day42.9%1.6%1.0%
30 Day11.1%-4.4%-0.4%
90 Day-9.1%1.1%8.9%
1 Yearn/a17.4%15.9%16.2%13.6%
3 Yearn/a29.1%23.4%40.2%30.8%
5 Yearn/a52.8%42.1%89.6%68.2%

Price Volatility Vs. Market

How volatile is Fuse Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Fuse Medical undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Fuse Medical is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Fuse Medical has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of FZMD's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Fuse Medical regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Fuse Medical forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Fuse Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of FZMD’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Fuse Medical's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Fuse Medical performed over the past 5 years?

-48.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: FZMD is currently unprofitable.

Growing Profit Margin: FZMD is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: FZMD is unprofitable, and losses have increased over the past 5 years at a rate of 48.3% per year.

Accelerating Growth: Unable to compare FZMD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FZMD is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: FZMD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is Fuse Medical's financial position?


Financial Position Analysis

Short Term Liabilities: FZMD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: FZMD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: FZMD has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: FZMD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: FZMD's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if FZMD's interest payments on its debt are well covered by EBIT.


Balance Sheet


Next Steps

Dividend

What is Fuse Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate FZMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate FZMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if FZMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if FZMD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of FZMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.4yrs

Average management tenure


CEO

Chris Reeg (56 yo)

3.75yrs

Tenure

US$302,085

Compensation

Mr. Christopher C. Reeg, also known as Chris, has been Chief Executive Officer and Director of Fuse Medical, Inc. since December 19, 2016 and is its Secretary since January 18, 2018. He serves as the Presi ...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD302.09K) is below average for companies of similar size in the US market ($USD595.72K).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Mark Brooks
Chairman of the Board & President3.75yrsUS$1.31m79%
$ 5.5m
Christopher Reeg
CEO, Secretary & Director3.75yrsUS$302.09k0.68%
$ 47.6k
William McLaughlin
Senior VP3.75yrsUS$200.00k0.68%
$ 47.6k

3.4yrs

Average Tenure

56yo

Average Age

Experienced Management: FZMD's management team is considered experienced (3.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Mark Brooks
Chairman of the Board & President3.75yrsUS$1.31m79%
$ 5.5m
Christopher Reeg
CEO, Secretary & Director3.75yrsUS$302.09k0.68%
$ 47.6k
William McLaughlin
Senior VP3.75yrsUS$200.00k0.68%
$ 47.6k
Renato Bosita
Independent Director3.08yrsUS$100.00k2.1%
$ 147.6k

3.8yrs

Average Tenure

55yo

Average Age

Experienced Board: FZMD's board of directors are considered experienced (3.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Fuse Medical, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Fuse Medical, Inc.
  • Ticker: FZMD
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: US$7.022m
  • Shares outstanding: 70.22m
  • Website: https://www.fusemedical.com

Location

  • Fuse Medical, Inc.
  • 1565 North Central Expressway
  • Suite 200
  • Richardson
  • Texas
  • 75080
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
FZMDOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJan 2018

Biography

Fuse Medical, Inc. manufactures and distributes medical devices implants in the United States. The company offers orthopedic implants, including internal and external fixation products; upper and lower ext ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/19 06:12
End of Day Share Price2020/09/14 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.